Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial

Fertil Steril. 2008 Oct;90(4):1283-6. doi: 10.1016/j.fertnstert.2007.09.004. Epub 2007 Dec 20.

Abstract

We investigated whether poor adherence with metformin tablets may have contributed to the poor success rates seen in the metformin-containing arms of the Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial. Median adherence for both metformin and clomiphene citrate tablets was within acceptable limits and unrelated to ovulation: thus, failure to comply with physician recommendations for metformin dosing was not the reason for low ovulation and pregnancy rates in the PPCOS Trial.

Publication types

  • Controlled Clinical Trial
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clomiphene / administration & dosage*
  • Community Networks
  • Drug Therapy, Combination
  • Female
  • Fertility Agents, Female / administration & dosage
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Infertility, Female / drug therapy*
  • Infertility, Female / epidemiology*
  • Metformin / administration & dosage*
  • National Institute of Child Health and Human Development (U.S.)
  • Patient Compliance / statistics & numerical data*
  • Polycystic Ovary Syndrome / drug therapy*
  • Polycystic Ovary Syndrome / epidemiology*
  • Pregnancy
  • Pregnancy Outcome / epidemiology*
  • Treatment Outcome
  • United States / epidemiology

Substances

  • Fertility Agents, Female
  • Hypoglycemic Agents
  • Clomiphene
  • Metformin